Interventional Cardiology Devices Market Insights on Trends and Growth Forecast by 2032

The global demand for interventional cardiology devices market is predicted to expand at an 8.4% CAGR from 2022 to 2032. The interventional cardiology equipment market is expected to be valued US$ 16.4 billion in 2022 and US$ 36.9 billion by 2032.

The trajectory of interventional cardiology device adoption trends is rising as a result of the numerous advantages of minimally invasive surgeries, such as reduced surgical pain, injury, and shorter recovery time when compared to conventional surgeries, proving to be a viable alternative to open surgery.

Demand for interventional cardiology devices is expected to drive the market throughout the projected period, owing to manufacturers' focus on major R&D to give important solutions to the healthcare sector.

Diabetes is more likely to be linked to other conditions that raise the risk of coronary heart disease. Diabetes and hypertension are two additional risk factors driving the demand for interventional cardiology equipment.

According to the American Heart Association, by 2035, around 45% of the US population will have heart disease as a result of factors such as high obesity, excessive smoking, and poor lifestyles, which can lead to heart attacks and other complications.

Furthermore, 1.5 million Americans are diagnosed with diabetes in the United States alone each year. Diabetes prevalence is rising as the elderly population grows; it is estimated that 25% of all geriatric persons (aged 60 and more) in the United States have diabetes.

A few key players in the interventional cardiology devices market are

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Edward Lifesciences Corporation
  • Cardinal Health

Get More Insights@ https://www.futuremarketinsights.com/reports/interventional-cardiology-devices-market

Key Segments

By Product:

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-mental Stents
    • Bioabsorbable Stents
  • Structural Heart Devices
    • Aortic Valve Therapy Devices
    • Other Therapy Devices
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Hemostasis Valves
    • Balloon Inflation Devices

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more